Oblenio Bio: Funding, Investors & Team (Sep 2026)
Oblenio Bio is a biotechnology company that develops T-cell engager therapeutic candidates for autoimmune disease treatment.
Oblenio Bio has raised $62.0M across 1 funding round on record, the most recent a Series B of $62.0M announced in Jun 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Oblenio Bio Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Oblenio Bio Funding Rounds
Oblenio Bio Founders and Leadership Team
No contact details are on record for this team yet.
Oblenio Bio Funding Compared to Other Biotechnology Startups
Oblenio Bio's latest round of $62.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Oblenio Bio in Biotechnology and Oakland
Companies Similar to Oblenio Bio
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Oblenio Bio Funding FAQs
What does Oblenio Bio do?
Oblenio Bio is a biotechnology company that develops T-cell engager therapeutic candidates for autoimmune disease treatment.
How much funding has Oblenio Bio raised?
Oblenio Bio has raised $62.0M across 1 round on record. The most recent is a Series B of $62.0M announced in Jun 2026.
When did Oblenio Bio last raise funding?
Oblenio Bio's most recent funding round on record is a Series B of $62.0M, announced in Jun 2026.
Who founded Oblenio Bio?
FundedIQ lists Samantha Truex (Founder) at Oblenio Bio.
Where is Oblenio Bio headquartered?
Oblenio Bio is based in Oakland, California, United States.
How many employees does Oblenio Bio have?
Oblenio Bio is in the 1-10 employee band.
How does Oblenio Bio's funding compare to other Biotechnology startups?
Oblenio Bio's latest round of $62.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Oblenio Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Oblenio Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.